Incyte (INCY) Misses Q4 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts INCY Hot Sheet
Price: $122.44 +4.12%
Financial Fact:
Diluted (in dollars per share): 0.19
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Diluted (in dollars per share): 0.19
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Incyte (NASDAQ: INCY) reported Q4 EPS of $1.06, $0.08 worse than the analyst estimate of $1.14. Revenue for the quarter came in at $1.01 billion versus the consensus estimate of $1.01 billion.
For earnings history and earnings-related data on Incyte (INCY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MFA Financial (MFA) Misses Q3 EPS by 2c
- Incyte (INCY) PT Raised to $108 at Bernstein SocGen Group
- Incyte to Present New Data Highlighting Progress Across its Hematology Portfolio at ASH 2026
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
